Phase 3CompletedAge-related condition

Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis

Phase III Clinical Trial to Evaluate the Efficacy and Safety of Chondroitin Sulfate and Glucosamine Sulfate in Combination Versus Placebo in Patients With Osteoarthritis of the Knee

Sponsor
Tedec-Meiji Farma, S.A. (Industry)
Enrollment
158 enrolled
Conditions
Knee Osteoarthritis
Interventions
CS+SG; Placebo
Ages
adults, older adults
Registry
NCT01893905, EUCTR2013-000444-26

Full record on ClinicalTrials.gov

From the registry

The main objective is to assess the efficacy of a new formulation containing chondroitin sulfate and glucosamine sulfate (CS+GS) compared with placebo in patients with primary osteoarthritis of the knee.

Primary outcomes

  • Change in Pain According to VAS (0-100 mm)

History

  1. Results first posted

  2. Last registry update

  3. Primary completion

  4. Registered

  5. Started

Papers citing this trial